ID   EB33
AC   CVCL_8344
SY   EB 33; EB-33
DR   BioSample; SAMN03151687
DR   Wikidata; Q54831750
RX   CelloPub=CLPUB00262;
RX   PubMed=87387;
RX   PubMed=93571;
RX   PubMed=372824;
RX   PubMed=535908;
RX   PubMed=1246601;
RX   PubMed=4374785;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=93571; PubMed=6451928; PubMed=1246601; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00023.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
RX   CelloPub=CLPUB00262;
RA   Gold M.;
RT   "A conspiracy of cells. One woman's immortal legacy and the medical
RT   scandal it caused.";
RL   (In book) ISBN 9780887060991; pp.1-171; State University of New York Press; Albany; USA (1986).
//
RX   PubMed=87387;
RA   Pontes J.E., Choe B.-K., Rose N.R., Pierce J.M. Jr.;
RT   "Immunochemical identification of prostatic epithelial cells in
RT   culture.";
RL   Invest. Urol. 16:483-485(1979).
//
RX   PubMed=93571; DOI=10.1007/BF02618148;
RA   Pontes J.E., Pierce J.M. Jr., Choe B.-K., Rose N.R.;
RT   "MA 160 and EB33 cell lines: HeLa cell contaminants, hybrids or
RT   prostatic epithelial cells?";
RL   In Vitro 15:469-472(1979).
//
RX   PubMed=372824;
RA   Schroeder F.H., Jellinghaus W.;
RT   "EB 33, an epithelial cell line from human prostate carcinoma: a
RT   review.";
RL   Natl. Cancer Inst. Monogr. 49:41-46(1978).
//
RX   PubMed=535908; DOI=10.1007/BF02619151;
RA   Nelson-Rees W.A.;
RT   "Prostatic acid phosphatase in cell lines MA 160, EB33 and HeLa
RT   cells.";
RL   In Vitro 15:935-935(1979).
//
RX   PubMed=1246601; DOI=10.1126/science.1246601;
RA   Nelson-Rees W.A., Flandermeyer R.R.;
RT   "HeLa cultures defined.";
RL   Science 191:96-98(1976).
//
RX   PubMed=4374785; DOI=10.1007/BF00254727;
RA   Okada K., Schroder F.H.;
RT   "Human prostatic carcinoma in cell culture: preliminary report on the
RT   development and characterization of an epithelial cell line (EB 33).";
RL   Urol. Res. 2:111-121(1974).
//
RX   PubMed=6451928; DOI=10.1126/science.6451928;
RA   Nelson-Rees W.A., Daniels D.W., Flandermeyer R.R.;
RT   "Cross-contamination of cells in culture.";
RL   Science 212:446-452(1981).
//
RX   PubMed=20143388; DOI=10.1002/ijc.25242;
RA   Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A.,
RA   MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R.,
RA   Freshney R.I.;
RT   "Check your cultures! A list of cross-contaminated or misidentified
RT   cell lines.";
RL   Int. J. Cancer 127:1-8(2010).
//